These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 12000986
1. Susceptibility of Brazilian staphylococcal strains to glycopeptides evaluated by different testing methods. Ferreira Nunes AP, Martins Teixeira L, Reis Bastos CC, de Souza Fonseca L, Netto dos Santos KR. Curr Microbiol; 2002 Jun; 44(6):385-90. PubMed ID: 12000986 [Abstract] [Full Text] [Related]
7. [Prospective study of Staphylococcus aureus with reduced susceptibility to glycopeptides]. Cantón R, Mir N, Martínez-Ferrer M, Sánchez del Saz B, Soler I, Baquero F. Rev Esp Quimioter; 1999 Mar; 12(1):48-53. PubMed ID: 10896469 [Abstract] [Full Text] [Related]
8. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology. Boisson K, Thouverez M, Talon D, Bertrand X. Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):660-5. PubMed ID: 12373498 [Abstract] [Full Text] [Related]
10. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs. Vedel G, Leruez M, Lémann F, Hraoui E, Ratovohery D. Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815 [Abstract] [Full Text] [Related]
11. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals. Cartolano GL, Cheron M, Benabid D, Leneveu M, Boisivon A, Association of Hospital Bacteriologists, Virologists and Hygiene Professionals. Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324 [Abstract] [Full Text] [Related]
15. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides. Del' Alamo L, Cereda RF, Tosin I, Miranda EA, Sader HS. Diagn Microbiol Infect Dis; 1999 Jul; 34(3):185-91. PubMed ID: 10403098 [Abstract] [Full Text] [Related]
16. Low-level resistance to glycopeptides amongst staphylococcus species: surveillance in a university hospital and evaluation of a vancomycin screening agar. Park YJ, Jun Park J, Lee SO, Oh EJ, Kee Kim B. Diagn Microbiol Infect Dis; 2001 Nov; 41(3):155-9. PubMed ID: 11750170 [Abstract] [Full Text] [Related]
17. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD. Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [Abstract] [Full Text] [Related]
18. Susceptibility of gram positive cocci to teicoplanin. Three year survey (1984-1986) at Perugia University. Pasticci MB, Baldelli F, Moretti A, Menichetti F, Pauluzzi S. Boll Ist Sieroter Milan; 1989 Aug; 68(1):5-6. PubMed ID: 2535245 [Abstract] [Full Text] [Related]